Loxapine Succinate
Especificaciones
27833-64-3Número CAS
248-682-0Número CE
butanedioic acid;8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepineNombre IUPAC
C22H24ClN3O5Fórmula química
445.9 g/molPeso molecular
Loxapine succinate; 27833-64-3; Loxapac; Cloxazepin; Daxolin; CL 71563; DTXSID3045227; X59SG0MRYU; NSC-759578; CL-71563; DTXCID1025227; CHEBI:6549; Loxipine Succinate; Loxapinsuccinate; Succinate, Loxapine; RefChem:58498; 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine Succinate(1:1); 248-682-0; Butanedioic Acid, compound with 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine(1:1); Loxapine succinate salt; Loxapine, Succinate; Loxitane; Loxapine (succinate); MFCD00069298; CPD000058470; MLS000069383; Loxapine.succinate; NCGC00016160-02; Lederle; SMR000058470; CAS-27833-64-3; 2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz[b,f][1,4]oxazepine succinate; 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine succinate (1:1); Loxapine succinate [USAN]; CCRIS 1917; AZ-004; SR-01000002971; EINECS 248-682-0; UNII-X59SG0MRYU; C22H24ClN3O5; Loxapine succinate [USAN:USP]; Staccato-loxapine; Loxitane (TN); Prestwick_304; Lopac-L-106; Opera_ID_1518; Loxapine succinate (USP); SCHEMBL41643; MLS000758291; MLS001146961; MLS001401432; MLS002222201; SPECTRUM2300242; Loxapine succinate salt, solid; REGID_for_CID_71399; orb1225446; orb1308691; LOXAPINE SUCCINATE [MI]; CHEMBL1201155; SCHEMBL29414130; SCHEMBL30201498; Loxapine (succinate) (Standard); GLXC-06117; HMS1568K06; HMS1922L14; HMS2051E05; HMS2093N20; HMS2095K06; HMS2232N05; HMS3262O21; HMS3374F02; HMS3393E05; HMS3652O10; HMS3712K06; HMS3885H03; HMS5082M10; HY-17390AR; LOXAPINE SUCCINATE [VANDF]; Pharmakon1600-02300242; LOXAPINE SUCCINATE [MART.]; LOXAPINE SUCCINATE [USP-RS]; LOXAPINE SUCCINATE [WHO-DD]; MSK11209; Tox21_110311; Tox21_500720; AZ-104; CCG-39497; EBC-12876; HY-17390A; NSC759578; s4086; AKOS015994711; Tox21_110311_1; CS-4285; FL33800; KS-1083; LP00720; NC00011; NSC 759578; LOXAPINE SUCCINATE [ORANGE BOOK]; NCGC00016160-01; NCGC00016160-03; NCGC00016160-04; NCGC00016160-05; NCGC00021145-11; NCGC00094068-01; NCGC00094068-02; NCGC00094068-03; NCGC00261405-01; AC-37650; DA-55019; LOXAPINE SUCCINATE [USP MONOGRAPH]; Succinic acid, compound with 2-chloro-11-(4-methylpiperazin-1-yl)dibenz(b,f)(1,4)oxazepine (1:1); EU-0100720; NS00084038; SW196603-4; VU0239541-8; D00794; F14786; EN300-6477859; F862294; L589921; SR-01000002971-2; SR-01000002971-6; SR-01000002971-9; Loxapine.succinate, 1mg/ml in Methanol (as free base); Q27107236; Z2756516768; 2-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine succinate; 2-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepinesuccinate; Loxapine succinate, United States Pharmacopeia (USP) Reference Standard; 8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine;succinic acid; Butanedioic acid--2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine (1/1); 13-chloro-10-(4-methylpiperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaene; butanedioic acidSinónimos
